Recent Acquisition Oncomfort was acquired by HypnoVR, a French VR-based digital therapy provider, presenting an opportunity for cross-selling and exploring new market segments through synergies.
Strategic Partnership The partnership with Vygon SA for distribution of Sedakit in multiple European countries opens doors for increased sales channels and market penetration.
Successful Product Launch The successful launch of Sedakit in Benelux countries and France, with over 30,000 users, indicates a strong market demand, providing a fertile ground for expanding sales efforts.
Significant Funding Round With a Series A funding of $9.99M co-led by Debiopharm and Crédit Mutuel Innovation, Oncomfort is well-positioned to scale up sales operations and product innovation.
Recognized Excellence Oncomfort's multiple awards in clinical application, innovation, and entrepreneurship enhance credibility, attracting potential customers seeking high-quality digital sedation solutions.